FORT DETRICK, Md. – In a critical effort to ensure peak medical readiness for the Navy's hospital ships (T-AH), subject matter experts from across Navy Medicine gathered at Naval Medical Readiness Logistics Command (NMRLC) Detachment Fort Detrick to review the Authorized Medical Allowance List (AMAL) for pharmacy and anesthesia, key components supporting Role 3 medical care.

Hospital ships operate as floating trauma centers and acute surgical hospitals, often deploying worldwide to support humanitarian assistance and disaster relief missions. Their effectiveness depends on having the right medical equipment and supplies, particularly in specialized areas such as pharmacy and anesthesia.

The importance of ensuring ships deploy with the right medical capabilities was recently demonstrated during Builder’s Sea Trials aboard the aircraft carrier PCU John F. Kennedy (CVN 79), when the ship’s medical team successfully performed an emergency appendectomy while underway in the Atlantic Ocean. Conducted with the ship’s onboard surgical equipment and supplies, the procedure highlighted how careful planning and provisioning enable lifesaving care even while operating far from shore.


The team at NMRLC Detachment Fort Detrick contributed to that readiness by overseeing procurement and initial outfitting of the carrier’s medical department before sea trials. Efforts like these, ensuring the right pharmaceuticals, anesthesia systems, surgical instruments, and consumables are available when needed, mirror the same deliberate process Navy Medicine leaders use when reviewing and refining AMALs to support operational medical capability across the fleet.

Work performed at Fort Detrick ultimately helps ensure that, whether aboard a hospital ship, aircraft carrier, or deployed naval unit, medical teams have the resources needed to deliver lifesaving care anytime, anywhere.

The collaborative meeting brought together logistics experts, Hospital Corpsmen, and clinical leaders representing Military Sealift Command, Defense Health Agency, NMRLC Williamsburg, and the hospital ships USNS Mercy (T-AH-19) and USNS Comfort (T-AH-20). Their combined expertise helped validate and refine the lists of pharmaceuticals, anesthesia supplies, and other consumables, ensuring the medical allowances align with each ship’s Required Operational Capability (ROC) and Projected Operating Environment (POE) while reflecting current clinical standards and lessons learned from recent humanitarian missions.

“The AMAL review is fundamental to our ability to provide advanced medical and surgical services afloat,” said Lt. Cmdr. Telia Wright, officer in charge of NMRLC Detachment Fort Detrick. “For hospital ships delivering Role 3 care, maintaining a robust and current pharmacy and anesthesia inventory is not just a logistical detail; it is the foundation of their lifesaving mission during a crisis.”

Role 3 care represents a theater-level hospital capability, providing services ranging from resuscitation and surgery to post-operative care and intensive care treatment. Anesthesiologists and pharmacists play a critical role in this process by managing pain, preparing patients for complex procedures, and ensuring the safe administration of medications. Regular AMAL reviews ensure these specialists have the tools, from general anesthetics to critical-care medications, required to operate effectively in austere and demanding environments.

By refining these medical loadouts, Navy Medicine strengthens the entire supply chain and improves the resilience and readiness of the fleet. Ensuring hospital ships are properly equipped enables Navy Medicine to deliver world-class medical support while projecting hope and healing to nations in need.

Headed by Capt. Christopher Barnes, NMRLC develops, acquires, produces, fields, sustains, and provides enduring lifecycle support of medical materiel solutions to the Fleet, Fleet Marine Force, and Joint Forces in high-end competition, crisis, and combat. At the forefront of Navy Medicine’s strategic evolution, NMRLC is well-positioned to be the Joint Force’s premier integrated medical logistics support activity.